Kairos Pharma, Ltd. financial statements
Kairos Pharma, Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 5.45M | 10-K |
| Cash and equivalents | USD 4.49M | 10-Q |
Kairos Pharma, Ltd. financials on 6ix · Kairos Pharma, Ltd. on 6ix